Company news
Virbac Sa (EURONEXT:VIRP) news
Virbac Sa news releases on 6ix. Latest, Sep 28, 2026: Virbac : Evolution of the Virbac Board of Directors
Press releases & updates
Virbac : Evolution of the Virbac Board of Directors
September 28, 2026
VIRBAC: A robust adjusted EBIT margin² of 18.8%, driven by solid organic revenue growth of 7.4%
September 17, 2026
Virbac : rapport semestriel 2026
September 16, 2026
Nominate a Deserving Organization: Virbac Recognizes Animal Charities Through Every Pet Project
September 9, 2026
Virbac : Declaration of the number of shares and voting rights 08/2026
September 7, 2026
Virbac : Déclaration d'actions et de droits de vote 08/2026
September 6, 2026
Virbac: solid growth of +7.4% at CERS in H1 2026, fueled by double-digit growth of our Supercharge4 platforms
July 20, 2026
Virbac: croissance solide de +7,4 % à PCC au premier semestre 2026, portée par la hausse à deux chiffres de nos plateformes Supercharge⁴
July 19, 2026
Virbac : Public release of Virbac Annual Report at 31 December 2025.
April 27, 2026
Leading with Care: Virbac Becomes a Human-Animal Bond Certified Company
April 22, 2026
Swine health: Virbac signs agreement with MACSO
April 17, 2026
Virbac: strong Q1 2026 growth of +7.7% at CERS, driven by double-digit growth of our priority Supercharge4 platforms
April 16, 2026
Virbac : Declaration of the number of shares and voting rights 03/2026
April 7, 2026
Virbac : 2025 full-year results
March 18, 2026
Virbac: 2025 annual results
March 17, 2026
Virbac : recognized as "2026 Industry ESG Leader"
March 16, 2026
Virbac : Declaration of the number of shares and voting rights 02/2026
March 10, 2026
Virbac : Declaration of the number of shares and voting rights 01/2026
February 5, 2026
Virbac: solid 2025 dynamic with annual revenue up +7.9% at CERS3; with strong momentum in key categories and countries
January 19, 2026
Virbac : Declaration of the number of shares and voting rights 12/2025
January 9, 2026
VIRBAC: Feline Hyperthyroidism: Virbac acquires Thyronorm
December 16, 2025
Virbac : Declaration of the number of shares and voting rights 11/2025
December 8, 2025
Virbac : Declaration of the number of shares and voting rights 10/2025
November 7, 2025
VIRBAC Announces Third Quarter 2025 Sales
October 16, 2025
Virbac : Next-generation collar for long-lasting parasite protection in cats and dogs
October 14, 2025
Virbac : Declaration of the number of shares and voting rights 09/2025
October 3, 2025
Virbac : introduces world-first medicated feed for cats
September 24, 2025
Virbac: 2025 Half-year results
September 12, 2025
Virbac : Declaration of the number of shares and voting rights 08/2025
September 5, 2025
Virbac : Declaration of the number of shares and voting rights 07/2025
September 5, 2025
Virbac:: Paul Martingell's compensation terms
August 18, 2025
Virbac: in the first half of 2025, revenue recorded solid growth of +5.6% at constant exchange rates and scope of consolidation
July 16, 2025
Virbac : Declaration of the number of shares and voting rights 06/2025
July 4, 2025
VIRBAC: Paul Martingell is appointed chief executive officer of Virbac, effective September 1, 2025
June 19, 2025
Virbac : Declaration of the number of share and voting rights 05/2025
June 10, 2025
Virbac : Declaration of the number of shares and voting rights 04/2025
May 7, 2025